Clinical Impact of CAUTI

Each year in U.S. hospitals there are an estimated 1.7 million healthcare acquired infections (HAI) resulting in approximately 99,000 deaths.[1] These infections can dramatically increase patient morbidity and mortality and have significant economic consequences for healthcare institutions.

UTIs account for approximately 36% of all HAIs (table 1), [1] and of those, eighty percent (80%) are associated with urinary catheterization.[2]  UTIs are the second most common cause of bloodstream infections and due to their frequency and subsequent treatment, UTIs have been referred to as the largest breeding ground for antibiotic resistant organisms.[3]

 Frequency of Hospital Acquired Infections


According to the CDC, UTIs are directly related to 5% of deaths associated with HAIs and may contribute to 11% of HAI's.[3]  In a recent report, “Estimating Healthcare Infections and Deaths in U.S. Hospitals in 2002,” UTIs were shown to be the third leading cause of death among patients with HAIs.  (Table 2) [1]

Estimated HAI Deaths in 2002

The emergence of HAIs as an important healthcare challenge has grown, due in part to legislative activity surrounding the mandatory reporting of infections.  Many states have now mandated the public reporting of infection rates, with many other states considering similar laws.  In addition, The Centers for Medicare and Medicaid Services are implementing payment reforms which will no longer reimburse hospitals for eight hospital acquired conditions, one of them being hospital acquired catheter associated urinary tract infections (CAUTI).

Bard has developed a novel solution to CAUTIs – The Bardex® I.C. Foley catheter with Bacti-Guard® Silver Alloy coating and Bard® Hydrogel.  This unique Foley catheter has been clinically proven to reduce the incidence of CAUTI.  Clinical studies have shown that the occurrence of UTI is 3.7 times greater in patients catheterized with a standard catheter than in patients catheterized with the Bardex® I.C. Foley catheter.

  1. Klevens RM. Et al., “Estimating Healthcare Associated Infections and Deaths in U.S. Hospitals, 2002.”  Public Health Reports, 2007, 122:160-166
  2. Salgado CD, Karchmer TB, Farr BM. Prevention of catheter-associated urinary tract infections. In :Wenzel RP, ed.Prevention and Control of Nosocomial Infections. 4th ed. Philadelphia: Lippincott Williams & Wilkins. 2003; 297-311.
  3. Maki DG, Tambyah PA. Engineering out the risk of infection with urinary catheters. Emerging Infectious Diseases. 2001;7:342-347.
  4. Klevens RM. Et al., “Estimating Healthcare Associated Infections and Deaths in U.S. Hospitals, 2002.”  Public Health Reports, 2007, 122:160-166


This site is intended for healthcare professionals. If you are a patient seeking more information regarding Catheter Associated Urinary Tract Infection (CAUTI) prevention, please consult your healthcare provider.